HBIOVSMRNA• 7 Days (Normalized)
HBIO vs MRNA (Harvard Bioscience Inc. vs Moderna Inc.)
Showing Closing Date Range from Sep, 10 to Sep, 17, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
HBIO Performance $8.03
-1.47%
Harvard Bioscience Inc.
Normalized Baseline0.00%
MRNA Performance $158.07
+15.7%
Moderna Inc.
Normalized Baseline0.00%
Alpha Spread Margin MRNA LEADS
-17.17%
MRNA outperforming by 17.17%
HBIOMRNA
Spread Trajectory7 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
HBIO MRNA
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(6 dates)
| Date | HBIO Price | HBIO Gain (%) | MRNA Price | MRNA Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 17, 2026 | $8.03 | -1.47% | $158.07 | +15.70% | -17.17% |
| Sep 16, 2026 | $7.97 | -2.21% | $145.62 | +6.59% | -8.80% |
| Sep 15, 2026 | $8.00 | -1.84% | $143.77 | +5.23% | -7.07% |
| Sep 14, 2026 | $8.09 | -0.74% | $146.69 | +7.37% | -8.11% |
| Sep 11, 2026 | $8.03 | -1.47% | $143.97 | +5.38% | -6.85% |
| Sep 10, 2026 | $8.15 | +0.00% | $136.62 | +0.00% | +0.00% |